CTRI/2023/02/049799尚未招募未知
A PROSPECTIVE, DOUBLE BLIND, RANDOMIZED CONTROLLED STUDY FORCOMPARING THE EFFICACY OF PERIOPERATIVE I.V LIGNOCAINE VS I.VMAGNESIUM SULFATE INFUSION IN ATTENUATING HEMODYNAMICPARAMETERS AND POSTOPERATIVE PAIN IN PATIENTS UNDERGOINGLAPAROSCOPIC HYSTERECTOMY
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients undergoing elective Laparoscopic Hysterectomy surgery under ASA-PS I&II
排除标准
- •Patient who refused to give informed and written consent
- •Patients of ASA-PS III%IV
- •Patients who are allergic to Lignocaine or Magnesium sulfate
- •Patients on opioid medications
研究者
相似试验
尚未招募
4 期
A STUDY TO COMPARE INTERATHECAL ROPIVACAINE HEAVY 0.75% AND BUPIVACAINE HEAVY 0.5 % IN ORTHOPAEDIC SURGERIES.CTRI/2024/02/063042Pacific medical college and hospital
尚未招募
1 期
A STUDY TO KNOW THE ADVANTAGE OF USING LOW DOSE SPINAL DRUG IN ANORECTAL SURGERIESCTRI/2023/10/058646K R HOSPITA
未知
不适用
A RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSISPER-071-11InterMune, Inc.,44
招募中
3 期
TRIAL EVALUATING EFFICACY AND SAFETY OF HYDROXYCHLOROQUINE VERSUS PLACEBO IN EARLY
SYSTEMIC SCLEROSIS (SSc)2024-516050-22-00Azienda Ospedaliero-Universitaria Policlinico Umberto I151
进行中（未招募）
1 期
TRIAL EVALUATING EFFICACY AND SAFETY OF HYDROXYCHLOROQUINE VERSUS PLACEBO IN EARLYSYSTEMIC SCLEROSIS (SSc)Systemic Sclerosis (SSc) is a rare and orphan disease (DPCM 12 gennaio 2017-GU SGn°65-S.O. n°15 - 18/03/2017), characterized by immunological, vascular and fibroticabnormalities. The estimated incidence is 18 to 20 cases per million population yearand a prevalence of 100 to 300 cases per million population. In Europe the prevalencerate is estimated around 200 per million while in the Italian population around 20000persons suffer from this form of autoimmune disease.MedDRA version: 20.0Level: SOCClassification code: 10040785Term: Skin and subcutaneous tissue disorders Class: 16MedDRA version: 20.0Level: SOCClassification code: 10047065Term: Vascular disorders Class: 12MedDRA version: 21.0Level: LLTClassification code: 10042953Term: Systemic sclerosis Class: 10028395MedDRA version: 20.0Level: SOCClassification code: 10028395Term: Musculoskeletal and connective tissue disorders Class: 17MedDRA version: 20.0Level: SOCClassification code: 10021428Term: Immune system disorders Class: 4MedDRA version: 20.0Level: SOCClassification code: 10017947Term: Gastrointestinal disorders Class: 14CTIS2024-516050-22-00Azienda Ospedaliero-Universitaria Policlinico Umberto I151